Split Creek Capital’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$327K Buy
5,247
+24
+0.5% +$1.52K 0.31% 99
2026
Q2
$301K Sell
5,223
-13
-0.2% -$746 0.28% 102
2026
Q1
$318K Buy
5,236
+1,462
+39% +$85.2K 0.33% 88
2025
Q4
$204K Buy
+3,774
New +$182K 0.22% 123

Other funds holding BMY

Split Creek Capital's BMY Position: Q3 2026 in Review

Split Creek Capital increased its Bristol-Myers Squibb (BMY) stake by 0.46% in Q3 2026, buying an estimated $1.52K and bringing the position to 5,247 shares worth $327K. The position accounts for 0.31% of the portfolio, ranked #99.

Split Creek Capital first reported a position in BMY in Q4 2025 and has held it in 4 quarters since. 2,253 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Split Creek Capital held 5,247 shares of Bristol-Myers Squibb worth $327K as of Q3 2026.
  • Split Creek Capital bought 24 Bristol-Myers Squibb shares in Q3 2026, an estimated $1.52K.
  • Bristol-Myers Squibb made up 0.31% of Split Creek Capital's portfolio in Q3 2026, its #99 holding.
  • Split Creek Capital first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 4 quarters since.
  • 2,253 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Split Creek Capital's 13F filing for Q3 2026, filed 2 Nov 2026.